Caxton Associates (New York)’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-22,005
| Closed | -$252K | – | 607 |
|
|
2023
Q2 | $252K | Sell |
22,005
-14,559
| -40% | -$167K | 0.04% | 377 |
|
|
2023
Q1 | $282K | Sell |
36,564
-70,132
| -66% | -$541K | 0.04% | 360 |
|
|
2022
Q4 | $651K | Sell |
106,696
-29,896
| -22% | -$182K | 0.04% | 176 |
|
|
2022
Q3 | $809K | Hold |
136,592
| – | – | 0.11% | 143 |
|
|
2022
Q2 | $807K | Hold |
136,592
| – | – | 0.08% | 153 |
|
|
2022
Q1 | $1.04M | Buy |
+136,592
| New | +$1.04M | 0.08% | 81 |
|